Pancreatic Cancer Research

ResearcherUniversity of PittsburghActive in the last 2 years

Amr I. Al Abbas

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5629-1060; OpenAlex author ID A5012396729. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
18
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper · 2020: 5 papers · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 8

  1. Minimally invasive pancreaticoduodenectomy: A favorable approach for frail patients with pancreatic cancer. First author DOI 10.1016/j.surg.2023.12.022↗
  2. Prognostic Value of the Systemic Immune-Inflammation Index (SII) After Neoadjuvant Therapy for Patients with Resected Pancreatic Cancer. Co-author DOI 10.1245/s10434-019-08094-0↗
  3. Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Adenocarcinoma. Co-author DOI 10.1245/s10434-019-08156-3↗
  4. Correction to: Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Adenocarcinoma. Co-author DOI 10.1245/s10434-020-08249-4↗
  5. ASO Author Reflections: Serum CA19-9 Utility in Pancreatic Adenocarcinoma in Patients Undergoing Neoadjuvant Therapy. Co-author DOI 10.1245/s10434-020-08342-8↗
  6. CA19-9 Change During Neoadjuvant Therapy May Guide the Need for Additional Adjuvant Therapy Following Resected Pancreatic Cancer. Co-author DOI 10.1245/s10434-020-08468-9↗
  7. Risk of Venous Thromboembolism for Patients with Pancreatic Ductal Adenocarcinoma Undergoing Preoperative Chemotherapy Followed by Surgical Resection. Co-author DOI 10.1245/s10434-018-07148-z↗
  8. CA19-9 on Postoperative Surveillance in Pancreatic Ductal Adenocarcinoma: Predicting Recurrence and Changing Prognosis over Time. Co-author DOI 10.1245/s10434-018-6521-7↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Herbert J. Zeh · 7 shared papers, 2018–2024 · strength 0.85
  2. Melissa Ellen Hogg · 6 shared papers, 2018–2020 · strength 0.77
  3. Amer H. Zureikat · 6 shared papers, 2018–2020 · strength 0.64
  4. Caroline J. Rieser · 5 shared papers, 2018–2020 · strength 0.52
  5. Ahmad B. Hamad · 4 shared papers, 2018–2020 · strength 0.42
  6. Nathan Bahary · 3 shared papers, 2018–2020 · strength 0.31
  7. Jae Pil Jung · 2 shared papers, 2020 · strength 0.24
  8. Brian A. Boone · 2 shared papers, 2019–2020 · strength 0.21
  9. Patricio Marcelo Polanco · 1 shared paper, 2024 · strength 0.21
  10. Adam Charles Yopp · 1 shared paper, 2024 · strength 0.21
  11. Matthew R. Porembka · 1 shared paper, 2024 · strength 0.21
  12. Sam C. Wang · 1 shared paper, 2024 · strength 0.21
  13. Emile Farah · 1 shared paper, 2024 · strength 0.21
  14. Pranav Murthy · 1 shared paper, 2020 · strength 0.11
  15. Michael T. Lotze · 1 shared paper, 2020 · strength 0.11
  16. Hao Liu · 1 shared paper, 2020 · strength 0.11
  17. Aatur Dilip Singhi · 1 shared paper, 2020 · strength 0.11
  18. Matthew D. Neal · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.